Estée Lauder
No proof required
Up to $5,000
Claims opening soon
Zantac
A Canada-wide class action alleges Zantac makers concealed cancer risks linked to ranitidine, seeking refunds and damages.
Opening soonOntario, QuebecClaim deadline: Pending court decisionEstimated payout: Compensation pendingClaims not open yet
About this settlement
The case concerns undisclosed cancer risks from ranitidine in Zantac products sold in Canada, with claims that manufacturers failed to warn consumers.
This class action targets manufacturers of Zantac and ranitidine generics for allegedly hiding cancer risks from consumers in Canada. The lawsuit seeks refunds, punitive damages, and other relief for those who purchased or ingested Zantac, which metabolizes into a probable carcinogen called NDMA.
Who qualifies
- Anyone in Canada who purchased or ingested Zantac or ranitidine products.
- Includes both over-the-counter and prescription ranitidine users.
- Residents of Canada, including Quebec and Ontario.
Compensation pending
Claim deadline: Pending court decision
Silk and Great Value
Proof required
Up to $300,000
84 days left
Audible
No proof required
Compensation pending
Claims opening soon
Government of Canada
Proof required
Up to $200,000
734 days left
Meta (Facebook)
No proof required
Up to $90
Claims opening soon
Ticketmaster
No proof required
Compensation pending
Claims opening soon